Adhesion Barrier Market: Growth, Size, Share, and Trends

Market Growth Outlook Summary

The global adhesion barrier market growth forecasted to transform from $0.7 billion in 2023 to $0.9 billion by 2028, driven by a CAGR of 7.4%. The major factors promoting the continued development of this market are the rise in geriatric population, an increasing number of surgeries and sports-related injuries, and the growing awareness for development of adhesions and complications associated with adhesion formation. On the other hand, during the forecast period, the resistance of surgeons to using adhesion barriers is anticipated to impede market expansion.

Global Adhesion Barrier Market Trends

To know about the assumptions considered for the study, Request for Free Sample Report

Adhesion Barrier Market Dynamics

Driver: Increase in the volume of surgeries and sports-related injuries

Adhesion formation is a major post-surgical complication and requires repeat surgeries for treatment in affected patients. Post-surgical adhesions lead to different complications in different surgeries, such as severe abdominal pain in the case of abdominal surgeries, infertility in women after gynecological surgeries, and physical impairment of patients after neurological surgeries. Considering the severe effects of post-surgery adhesions in patients, the importance of products such as adhesion barriers is increasing in the market. Also, considering the growth in the number of surgeries performed globally, the importance of these products will be more pronounced in the coming years.

Restraint: Reluctance of surgeons to use adhesion barriers

Even though surgeons are aware of these risks, they are reluctant to use adhesion barriers owing to the lack of/limited reliable clinical evidence supporting the safety and efficacy of commercialized adhesion barrier products. Also, due to issues regarding the safety and efficacy of adhesion barriers, companies find it difficult to get marketing approvals for their products.  Also, over the last few years, the market has witnessed the discontinuation of approved adhesion barrier products due to poor clinical outcomes.

Opportunity: Untapped emerging markets

The penetration of adhesion barriers is very low in the Asia Pacific, Latin America, and the Middle East and Africa. In the coming years, countries such as South Korea, China, India, Mexico, and Brazil are expected to offer significant growth opportunities for players operating in the adhesion barriers market as these countries have a large patient base for target indications, such as cardiovascular, orthopedic, general/abdominal, and gynecological disorders. The number of surgical procedures, such as cardiac surgeries, general and abdominal surgeries, urological surgeries, gynecological surgeries, and orthopedic surgeries, is also on the rise in countries across emerging markets.  Also, the number of surgeries being performed across APAC and the Middle East is increasing, owing to an increased influx of medical tourists in these regions. The increasing disease burden and volume of surgical procedures performed in emerging markets are expected to create growth opportunities for key players operating in the adhesion barriers market.

Challenge: Stringent regulations leading to limited technological innovations

The development of new adhesion barriers requires significant investments, and new products generally take more than 7–8 years to gain marketing approval. The cost and time required for a  product to enter the clinical trial stage and then clear the clinical trials are very high, with minimum chances of the product gaining approval. Also, the possibility of obtaining clinically significant data showing efficacy and safety has been low for most adhesion barriers, barring a few. Hence, despite huge investments in R&D, the risk of failure is very high in the case of adhesion barriers. This is a major factor limiting the development of novel adhesion barriers in the market.

Adhesion Barrier Market Ecosystem

The prominent players operating in the adhesion barriers market are Baxter International (US), Johnson & Johnson (J&J) (US), and Becton, Dickinson and Company (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll (Ireland), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Terumo Corporation (Japan), BiosCompass (US), W.L.Gore & Associates (US), GUNZE Limited (Japan), Leader Biomedical (Netherlands), Xlynk Surgical (US), Luna Solutions (US), PlantTec Medical GmbH (Germany), Actamax Surgical Materials, LLC (US), Arc Medical Devices, INC. (US), CG Bio INC. (Korea), Seikagaku Corporation (Japan), Hangzhou Singclean Medical Products Co.,Ltd (China)and Allosource (US).

The synthetic adhesion barrier product segment of the adhesion barrier industry is expected to grow the fastest during the forecast period.

Synthetic adhesion barriers are the most widely used post-surgical adhesion prevention products this segment accounted for the largest share of the adhesion barrier market in 2022 and is growing at the fastest rate with the highest CAGR. Owing to their resorbable features, synthetic barriers help prevent the requirement for a second surgery for implant removal. they are more cost-effective than natural adhesion barriers.

By formulation, the film-based formulations accounted for the largest share of the adhesion barrier industry in 2022

Depending on formulation type, the adhesion barrier market is segmented into film formulations, gel formulations, and liquid formulations. In 2022, film formulations dominated this market. The large share of this segment can be attributed to the availability of a wide range of film-form adhesion barriers and the strong clinical evidence supporting the safety and efficacy of these adhesion barriers. These  factors, coupled with their ease of use, have increased the adoption of film-form adhesion barriers among surgeons as compared to gel- and liquid-form adhesion barriers.

By End User, the hospital and clinics accounted for the largest share of the adhesion barrier industry in 2022

Depending on end user, the adhesion barrier market is segmented hospitals & clinics, ambulatory surgical centers and other end users. In 2022, hospitals & clinics dominated this market. The large share of this segment can be attributed to the fact that the large number of surgerical procedures are performed in the hospitals.

APAC region of the adhesion barrier industry will grow at the fastest rate during the forecast period.

The adhesion barrier market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific is the most lucrative healthcare market, owing to its large population and growing healthcare sector. Factors such as the rapid economic growth in China and Japan, presence of a universal healthcare reimbursement policy, large and growing population in countries like China and India, overall increasing disease prevalence at an alarming rate is leading Asia Pacific to grow at the fastest rate. Moreover, the government initiatives, such as the setting up of new healthcare systems for the aging population and increasing funds for infrastructural improvements in healthcare facilities and the increased demand for surgical interventions are driving the demand for better healthcare facilities, medical devices, and technologies in the region.

Geographic Snapshot: Adhesion Barrier Market

To know about the assumptions considered for the study, download the pdf brochure

The prominent players operating in the adhesion barriers market are Baxter International (US), Johnson & Johnson (J&J) (US), and Becton, Dickinson and Company (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll (Ireland), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Terumo Corporation (Japan), BiosCompass (US), W.L.Gore & Associates (US), GUNZE Limited (Japan), Leader Biomedical (Netherlands), Xlynk Surgical (US), Luna Solutions (US), PlantTec Medical GmbH (Germany), Actamax Surgical Materials, LLC (US), Arc Medical Devices, INC. (US), CG Bio INC. (Korea), Seikagaku Corporation (Japan), Hangzhou Singclean Medical Products Co.,Ltd (China) and Allosource (US).

Scope of the Adhesion Barrier Industry

The research report categorizes adhesion barrier market to forecast revenue and analyze trends in each of the following submarkets:

By Product

• Synthetic Products
  • Hyaluronic Acid
  • Regenerated Cellulose
  • Polyethylene Glycol
  • Other Synthetic Adhesion Barriers
• Natural Products

By Formulation

• Film Formulations
• Gel Formulations
• Liquid Formulations

By Application Area/Surgical Procedure

• Gynecological Surgeries
• General/Abdominal Surgeries
• Orthopedic Surgeries
• Cardiovascular Surgeries
• Neurological Surgeries
• Urological Surgeries
• Reconstructive Surgeries
• Other Surgeries

By End User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Other End Users

By Country

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Rest of LATAM
• Middle East and Africa

Recent Developments of Adhesion Barrier Industry

• In February 2020, Baxter’s acquired the Seprafilm Adhesion Barrier and related assets from Sanofi to strengthen its hemostate and sealant portfolio and company’s presence in this market.
• In January 2021, Integra Lifesciences Holdings Corporation acquired Acell Inc. This acquisition enables integra to provide more comprehensive complex wound management solutions

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst